Tusk Therapeutics Ltd
09918170
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2025
micro entity
Next accounts due
30/09/2027
Confirmation statement
Last: 15/09/2025
Due 29/09/2026
Industry
Officers
director · Since 11/08/2025
GENERAL MANAGER
AMERICAN · ENGLAND · Age 49
Also on 6 other boards
Persons with Significant Control
Roche Holding Ag
124, Grenzacherstrasse, 4085 Basel
Reg: Che101602521 · Basel, Switzerland · Aktiengesellschaft
Notified 05/10/2018
Former PSCs
Mr Luc Franciscus Cornelius Verelst
Ceased 27/09/2018
Tusk Therapeutics Sa
Ceased 06/04/2016
CompanyRankvs 29829+ SIC 74909 peers73
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£6.2M
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£6.2M
Working capital
Current Assets
£6.2M
Current Liabilities
£0
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | Infinity | +£0 |
| 2025 | Infinity | — |
Derived from filed accounts. Not audited figures.